In a pivotal ruling, the High Court in London has sided with Moderna in a patent dispute against Pfizer and BioNTech over their COVID-19 vaccines. The court found that Pfizer-BioNTech’s use of mRNA technology infringed on Moderna’s patented process involving modified RNA. Despite Pfizer and BioNTech’s arguments, the court upheld
Despite ongoing questions about its mRNA technology, Moderna has secured a $176 million U.S. government contract to develop a bird flu vaccine as concerns grow over the H5N1 virus spreading among dairy cows and workers. This funding will support advanced development and testing of the vaccine, with late-stage trials planned
The FDA approved Moderna’s new mRNA RSV vaccine, bypassing its independent vaccine advisory committee, which typically offers recommendations for such drugs. The mRNA respiratory syncytial virus (RSV) vaccine from Moderna was licensed by the U.S. Food and Drug Administration (FDA) last week for people 60 years of age and above.
Moderna’s stock surges as the US government invests millions in covert bird flu vaccine trials, amid concerns over H5N1’s spread and potential human-to-human transmission ahead of the presidential elections. In the New York premarket trading session, Moderna’s shares have increased by nearly 4% in response to a Financial Times report
According to an exclusive report by investigative journalists Lee Fang and Jack Poulson, Moderna has been reported to hire former FBI agents to secretly control the vaccine debate. Moderna, a pharmaceutical company, is using its disinformation department to monitor what it refers to as “vaccine misinformation” online. The goal is
A recent study (read below) shows that more heart damage occurs after receiving Moderna’s COVID-19 booster than previously believed. Researchers discovered that about 1 in 35 health care workers at a Swiss hospital who received the mRNA-1273 vaccine had signs of heart injury linked to it. Normally, this level would
According to John Campbell, Ph.D., who reported on his YouTube show, the UK has committed $1 billion to the development of Moderna mRNA flu vaccine, despite the fact that the vaccine is still in very early clinical trials. The National Institutes of Health is running a Phase 1 clinical trial on an
The US government has now invested nearly $6 billion in an effort led by President Biden to provide a lifeline to Moderna amid the COVID-19 crisis.
In an interview, Moderna’s President Stephen Hoge said that he expects its COVID vaccine to be priced at around $130 in the US.